{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:11:43Z","timestamp":1795050703107,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Shigellosis, caused by <jats:italic>Shigella<\/jats:italic> bacterial spp., is one of the leading causes of diarrheal morbidity and mortality. An increasing prevalence of multidrug-resistant Shigella species has revived the importance of bacteriophages as an alternative therapy to antibiotics. In this study, a novel bacteriophage, Sfk20, has been isolated from water bodies of a diarrheal outbreak area in Kolkata (India) with lytic activity against many <jats:italic>Shigella<\/jats:italic> spp. Phage Sfk20 showed a latent period of 20\u00a0min and a large burst size of 123 pfu per infected cell in a one-step growth analysis. Phage-host interaction and lytic activity confirmed by phage attachment, intracellular phage development, and bacterial cell burst using ultrathin sectioning and TEM analysis. The genomic analysis revealed that the double-stranded DNA genome of Sfk20 contains 164,878\u00a0bp with 35.62% G\u2009+\u2009C content and 241 ORFs. Results suggested phage Sfk20 to include as a member of the T4 myoviridae bacteriophage group. Phage Sfk20 has shown anti-biofilm potential against <jats:italic>Shigella<\/jats:italic> species. The results of this study imply that Sfk20 has good possibilities to be used as a biocontrol agent.<\/jats:p>","DOI":"10.1038\/s41598-021-98910-z","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:21:04Z","timestamp":1632910864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Morphological, biological, and genomic characterization of a newly isolated lytic phage Sfk20 infecting Shigella flexneri, Shigella sonnei, and Shigella dysenteriae1"],"prefix":"10.1038","volume":"11","author":[{"given":"Bani","family":"Mallick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payel","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"98910_CR1","first-page":"2905","volume-title":"Principles and Practice of Infectious Diseases","author":"HL DuPont","year":"2010","unstructured":"DuPont, H. L. Shigella species (bacillary dysentery). In Principles and Practice of Infectious Diseases (eds Mandell, G. L. et al.) 2905\u20132910 (Churchill Livingstone Elsevier, 2010)."},{"key":"98910_CR2","first-page":"133","volume":"43","author":"SK Niyogi","year":"2005","unstructured":"Niyogi, S. K. Shigellosis. J. Microbiol. 43, 133\u2013143 (2005).","journal-title":"J. Microbiol."},{"key":"98910_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","volume":"391","author":"KL Kotloff","year":"2018","unstructured":"Kotloff, K. L., Riddle, M. S., Platts-Mills, J. A., Pavlinac, P. & Zaidi, A. K. M. Shigellosis. Lancet 391, 801\u2013812 (2018).","journal-title":"Lancet"},{"key":"98910_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4103\/0971-5916.187104","volume":"143","author":"N Taneja","year":"2016","unstructured":"Taneja, N. & Mewara, A. Shigellosis: Epidemiology in India. Indian J. Med. Res. 143, 565\u2013576 (2016).","journal-title":"Indian J. Med. Res."},{"key":"98910_CR5","first-page":"81","volume":"1","author":"MB Zaidi","year":"2014","unstructured":"Zaidi, M. B. & Estrada-Garc\u00eda, T. Shigella: A highly virulent and elusive pathogen. Curr. Trop. Med. Rep. 1, 81\u201387 (2014).","journal-title":"Curr. Trop. Med. Rep."},{"key":"98910_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/20469047.2017.1409454","volume":"38","author":"PCM Williams","year":"2018","unstructured":"Williams, P. C. M. & Berkley, J. A. Guidelines for the treatment of dysentery (shigellosis): A systematic review of the evidence. Paediatr. Int. Child Health 38, 50\u201365 (2018).","journal-title":"Paediatr. Int. Child Health"},{"key":"98910_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrmicro1662","volume":"5","author":"MM Levine","year":"2007","unstructured":"Levine, M. M., Kotloff, K. L., Barry, E. M., Pasetti, M. F. & Sztein, M. B. Clinical trials of Shigella vaccines: Two steps forward and one step back on a long, hard road. Nat. Rev. Microbiol. 5, 540\u2013553 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"98910_CR8","first-page":"1","volume-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics 1\u20137 (WHO Press, 2017)."},{"key":"98910_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","volume":"1","author":"MRJ Clokie","year":"2011","unstructured":"Clokie, M. R. J., Millard, A. D., Letarov, A. V. & Heaphy, S. Phages in nature. Bacteriophage. 1, 31\u201345 (2011).","journal-title":"Bacteriophage."},{"key":"98910_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.cell.2017.10.045","volume":"172","author":"G Ofir","year":"2018","unstructured":"Ofir, G. & Sorek, R. Contemporary phage biology: From classic models to new insights. Cell 172, 1260\u20131270 (2018).","journal-title":"Cell"},{"key":"98910_CR11","doi-asserted-by":"crossref","unstructured":"Shan, J. et al. Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; Insights from HT-29 cells. Sci. Rep. 8 (2018).","DOI":"10.1038\/s41598-018-23418-y"},{"key":"98910_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.00882","volume":"7","author":"TE Nagel","year":"2016","unstructured":"Nagel, T. E. et al. The developing world urgently needs phages to combat pathogenic bacteria. Front Microbiol. 7, 1\u20134 (2016).","journal-title":"Front Microbiol."},{"key":"98910_CR13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/s0140-6736(01)20383-3","volume":"186","author":"FW Twort","year":"1915","unstructured":"Twort, F. W. An investigation on the nature of ultra-microscopic viruses. Lancet 186, 1241\u20131243. https:\/\/doi.org\/10.1016\/s0140-6736(01)20383-3 (1915).","journal-title":"Lancet"},{"key":"98910_CR14","unstructured":"d\u2019Herelle, F. Le bacteriophage. La Nature (1921)."},{"key":"98910_CR15","unstructured":"d\u2019Herelle, F. bacteriophages as a treatment in acute medical and surgical infections (1931)."},{"issue":"1","key":"98910_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-virology-010320-052547","volume":"7","author":"S Subramanian","year":"2020","unstructured":"Subramanian, S., Parent, K. N. & Doore, S. M. Ecology, structure, and evolution of Shigella phages. Annu. Rev. Virol. 7(1), 121\u2013141 (2020).","journal-title":"Annu. Rev. Virol."},{"key":"98910_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2174\/138920110790725401","volume":"11","author":"E Kutter","year":"2010","unstructured":"Kutter, E. et al. Phage therapy in clinical practice: Treatment of human infections. Curr. Pharm. Biotechnol. 11, 1169\u20131186 (2010).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"98910_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijantimicag.2018.09.004","volume":"53","author":"A Kakasis","year":"2019","unstructured":"Kakasis, A. & Panitsa, G. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Int. J. Antimicrob. Agents 53, 16\u201321 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"98910_CR19","first-page":"1","volume":"5","author":"A G\u00f3rski","year":"2010","unstructured":"G\u00f3rski, A. et al. Phage therapy: Beyond antibacterial action. Front Med. 5, 1\u20138 (2010).","journal-title":"Front Med."},{"key":"98910_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/138920110790725311","volume":"11","author":"J Gill","year":"2010","unstructured":"Gill, J. & Hyman, P. Phage choice, isolation, and preparation for phage therapy. Curr. Pharm. Biotechnol. 11, 2\u201314 (2010).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"98910_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004944","volume":"4","author":"M Merabishvili","year":"2009","unstructured":"Merabishvili, M. et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4, e4944 (2009).","journal-title":"PLoS ONE"},{"key":"98910_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00705-006-0849-1","volume":"152","author":"HW Ackermann","year":"2007","unstructured":"Ackermann, H. W. 5500 phages examined in the electron microscope. Arch Virol. 152, 227\u2013243 (2007).","journal-title":"Arch Virol."},{"key":"98910_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsle\/fnw002","volume":"363","author":"J Bertozzi Silva","year":"2016","unstructured":"Bertozzi Silva, J., Storms, Z. & Sauvageau, D. Host receptors for bacteriophage adsorption. FEMS Microbiol. Lett. 363, 1\u201311 (2016).","journal-title":"FEMS Microbiol. Lett."},{"key":"98910_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s13197-017-2964-2","volume":"55","author":"K Shahin","year":"2018","unstructured":"Shahin, K. & Bouzari, M. Bacteriophage application for biocontrolling Shigella flexneri in contaminated foods. J. Food Sci. Technol. 55, 550\u2013559 (2018).","journal-title":"J. Food Sci. Technol."},{"key":"98910_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.619323","volume":"12","author":"K Shahin","year":"2021","unstructured":"Shahin, K. et al. Biodiversity of new lytic bacteriophages infecting Shigella spp in freshwater environment. Front Microbiol. 12, 619323 (2021).","journal-title":"Front Microbiol."},{"issue":"1","key":"98910_CR26","first-page":"4","volume":"6","author":"S Albers","year":"2016","unstructured":"Albers, S. & Czech, A. Exploiting tRNAs to boost virulence. Life (Basel) 6(1), 4 (2016).","journal-title":"Life (Basel)"},{"key":"98910_CR27","doi-asserted-by":"crossref","unstructured":"Wittebole, X., Opal, S. & Witzany, G. Phagetherapy: Clinical applications \u2013 critical appraisal of randomized controlled trials. In: Biocommunication of Phages. 371\u2013383 (Springer International Publishing, 2020).","DOI":"10.1007\/978-3-030-45885-0_18"},{"key":"98910_CR28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. World Med. Assoc. JAMA 310, 2191\u20132194 (2013).","journal-title":"World Med. Assoc. JAMA"},{"key":"98910_CR29","first-page":"651","volume":"77","author":"KL Kotloff","year":"1999","unstructured":"Kotloff, K. L. et al. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77, 651 (1999).","journal-title":"Bull. World Health Organ."},{"key":"98910_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jac\/dkg080","volume":"51","author":"S Ashkenazi","year":"2003","unstructured":"Ashkenazi, S., Levy, I., Kazaronovski, V. & Samra, Z. Growing antimicrobial resistance of Shigella isolates. J. Antimicrob. Chemother. 51, 427\u2013429 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"98910_CR31","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1128\/jcm.30.6.1428-1431.1992","volume":"30","author":"MP Bratoeva","year":"1992","unstructured":"Bratoeva, M. P., John, J. F. & Barg, N. L. Molecular epidemiology of trimethoprim-resistant Shigella boydii serotype 2 strains from Bulgaria. J. Clin. Microbiol. 30, 1428\u20131431 (1992).","journal-title":"J. Clin. Microbiol."},{"key":"98910_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1756-0500-1-74","volume":"1","author":"R Ranjbar","year":"2008","unstructured":"Ranjbar, R., Mammina, C., Pourshafie, M. R. & Soltan-Dallal, M. M. Characterization of endemic Shigella boydii strains isolated in Iran by serotyping, antimicrobial resistance, plasmid profile, ribotyping and pulsed-field gel electrophoresis. BMC Res. Notes 1, 74 (2008).","journal-title":"BMC Res. Notes"},{"key":"98910_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftw027","volume":"74","author":"DA Kania","year":"2016","unstructured":"Kania, D. A., Hazen, T. H., Hossain, A., Nataro, J. P. & Rasko, D. A. Genome diversity of Shigella boydii. Pathog. Disease 74, ftw027 (2016).","journal-title":"Pathog. Disease"},{"key":"98910_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/cid\/ciu468","volume":"59","author":"S Livio","year":"2014","unstructured":"Livio, S. et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin. Infect. Diseases Off. Publ. Infect. Diseases Soc. Am. 59, 933\u2013941 (2014).","journal-title":"Clin. Infect. Diseases Off. Publ. Infect. Diseases Soc. Am."},{"key":"98910_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1017\/S0950268805004498","volume":"133","author":"GP Pazhani","year":"2005","unstructured":"Pazhani, G. P., Ramamurthy, T., Mitra, U., Bhattacharya, S. K. & Niyogi, S. K. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol. Infect. 133, 1089\u20131095 (2005).","journal-title":"Epidemiol. Infect."},{"key":"98910_CR36","doi-asserted-by":"crossref","unstructured":"Akter, M. et al. Prevalence of Shigella boydii in Bangladesh: Isolation and characterization of a rare phage MK-13 that can robustly identify Shigellosis caused by Shigella boydii type 1. Front. Microbiol. 10 (2019).","DOI":"10.3389\/fmicb.2019.02461"},{"key":"98910_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fmicb.2014.00051","volume":"5","author":"M Ly-Chatain","year":"2014","unstructured":"Ly-Chatain, M. The factors affecting effectiveness of treatment in phages therapy. Front. Microbiol. 5, 51 (2014).","journal-title":"Front. Microbiol."},{"key":"98910_CR38","first-page":"267","volume":"31","author":"S Slopek","year":"1983","unstructured":"Slopek, S. et al. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of results. Arch. Immunol. Ther. Exp. (Warsz) 31, 267\u2013291 (1983).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"98910_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik, D. J. et al. Formulation, stabilisation, and encapsulation of bacteriophage for phage therapy. Adv. Colloid Interface Sci. 249, 100\u2013133 (2017).","journal-title":"Adv. Colloid Interface Sci."},{"key":"98910_CR40","doi-asserted-by":"crossref","unstructured":"Nobrega, F. L. et al. Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine (2016).","DOI":"10.1038\/srep39235"},{"key":"98910_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4161\/bact.18778","volume":"2","author":"L Marinelli","year":"2012","unstructured":"Marinelli, L., Hatfull, G. & Piuri, M. Recombineering: A powerful tool for modification of bacteriophage genomes. Bacteriophage 2, 5\u201314 (2012).","journal-title":"Bacteriophage"},{"issue":"4","key":"98910_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cger.2016.06.011","volume":"32","author":"RE Docking","year":"2016","unstructured":"Docking, R. E. Role of emerging technologies in geriatric pain management. Clin. Geriatr. Med. 32(4), 787\u2013795 (2016).","journal-title":"Clin. Geriatr. Med."},{"key":"98910_CR43","first-page":"115","volume":"17","author":"M Bolger-Munro","year":"2013","unstructured":"Bolger-Munro, M., Cheung, K., Fang, A. & Wang, L. T4 Bacteriophage average burst size varies with Escherichia coli B23 cell culture age. J. Exp. Microbiol. Immunol. 17, 115\u2013119 (2013).","journal-title":"J. Exp. Microbiol. Immunol."},{"issue":"3","key":"98910_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0968-4328(94)00051-Q","volume":"26","author":"E Kellenberger","year":"1995","unstructured":"Kellenberger, E. & Wunderli-Allenspach, H. Electron microscopic studies on intracellular phage development\u2013history and perspectives. Micron (Oxford, England) 26(3), 213\u2013245 (1995).","journal-title":"Micron (Oxford, England)"},{"key":"98910_CR45","first-page":"268","volume":"9","author":"C Ferriol-Gonz\u00e1lez","year":"2020","unstructured":"Ferriol-Gonz\u00e1lez, C. & Domingo-Calap, P. Phages for biofilm removal. Antibiotics (Basel, Switzerland) 9, 268 (2020).","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"98910_CR46","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00253-015-7247-0","volume":"100","author":"DP Pires","year":"2016","unstructured":"Pires, D. P., Oliveira, H., Melo, L. D., Sillankorva, S. & Azeredo, J. Bacteriophage-encoded depolymerases: Their diversity and biotechnological applications. Appl. Microbiol. Biotechnol. 100, 2141\u20132151 (2016).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"98910_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.33073\/pjm-2014-019","volume":"63","author":"S Parasion","year":"2014","unstructured":"Parasion, S., Kwiatek, M., Gryko, R., Mizak, L. & Malm, A. Bacteriophages as an alternative strategy for fighting biofilm development. Pol. J. Microbiol. 63, 137\u2013145 (2014).","journal-title":"Pol. J. Microbiol."},{"key":"98910_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.mib.2008.09.012","volume":"11","author":"VA Fischetti","year":"2008","unstructured":"Fischetti, V. A. Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 11, 393\u2013400 (2008).","journal-title":"Curr. Opin. Microbiol."},{"key":"98910_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/1040841X.2012.723675","volume":"39","author":"L Rodr\u00edguez-Rubio","year":"2013","unstructured":"Rodr\u00edguez-Rubio, L., Mart\u00ednez, B., Donovan, D. M., Rodr\u00edguez, A. & Garc\u00eda, P. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit. Rev. Microbiol. 39, 427\u2013434 (2013).","journal-title":"Crit. Rev. Microbiol."},{"key":"98910_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107307","volume":"9","author":"D Guti\u00e9rrez","year":"2014","unstructured":"Guti\u00e9rrez, D., Ruas-Madiedo, P., Mart\u00ednez, B., Rodr\u00edguez, A. & Garc\u00eda, P. Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS ONE 9, e107307 (2014).","journal-title":"PLoS ONE"},{"key":"98910_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","volume":"25","author":"MS Bedi","year":"2009","unstructured":"Bedi, M. S., Verma, V. & Chhibber, S. Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiellapneumoniae B5055. World J MicrobiolBiotechnol. 25, 1145\u20131151 (2009).","journal-title":"World J MicrobiolBiotechnol."},{"key":"98910_CR52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/antibiotics3030270","volume":"3","author":"DR Harper","year":"2014","unstructured":"Harper, D. R. et al. Bacteriophages and biofilms. Antibiotics 3, 270\u2013284 (2014).","journal-title":"Antibiotics"},{"key":"98910_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168615","volume":"12","author":"WN Chaudhry","year":"2017","unstructured":"Chaudhry, W. N. et al. Synergy and order effects of antibiotics and phages in killing pseudomonas aeruginosa biofilms. PLoS ONE 12, e0168615 (2017).","journal-title":"PLoS ONE"},{"key":"98910_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000102469","volume":"50","author":"M Dutta","year":"2007","unstructured":"Dutta, M. & Ghosh, A. N. Physicochemical Characterization of El Tor Vibriophage S20. Intervirology 50, 264\u2013272 (2007).","journal-title":"Intervirology"},{"key":"98910_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-60327-164-6_14","volume":"501","author":"E Kutter","year":"2009","unstructured":"Kutter, E. Phage host range and efficiency of plating. Methods Mol. Biol. 501, 141\u2013149 (2009).","journal-title":"Methods Mol. Biol."},{"key":"98910_CR56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1128\/AEM.02889-14","volume":"81","author":"Y Yuan","year":"2015","unstructured":"Yuan, Y. et al. Effects of actin-like proteins encoded by two Bacillus pumilus phages on unstable lysogeny revealed by genomic analysis. Appl. Environ. Microbiol. 81, 339\u2013350 (2015).","journal-title":"Appl. Environ. Microbiol."},{"key":"98910_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000150026","volume":"29","author":"S Majumdar","year":"1988","unstructured":"Majumdar, S., Dey, S. N., Chowdhury, R., Dutta, C. & Das, J. Intracellular development of choleraphage \u03a6149 under permissive and nonpermissive conditions: An electron microscopic study. Intervirology 29, 27\u201338 (1988).","journal-title":"Intervirology"},{"key":"98910_CR58","doi-asserted-by":"publisher","first-page":"e01067","DOI":"10.1128\/IAI.01067-16","volume":"85","author":"KP Nickerson","year":"2017","unstructured":"Nickerson, K. P. et al. Analysis of Shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts. Infect. Immun. 85, e01067-e1116 (2017).","journal-title":"Infect. Immun."},{"key":"98910_CR59","first-page":"37","volume":"28","author":"M Yazdi","year":"2018","unstructured":"Yazdi, M., Bouzari, M. & Ghaemi, E. A. Isolation and characterization of a lytic bacteriophage (vB_PmiS-TH) and its application in combination with ampicillin against planktonic and biofilm forms of proteus mirabilis isolated from urinary tract infection. J. Mol. Microbiol. Biotechnol. 28, 37\u201346 (2018).","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"98910_CR60","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U. K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 227, 680\u2013685 (1970).","journal-title":"Nature"},{"key":"98910_CR61","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/bioinformatics\/bti054","volume":"21","author":"P Stothard","year":"2005","unstructured":"Stothard, P. & Wishart, D. S. Circular genome visualization and exploration using CGView. Bioinformatics 21, 537\u2013539 (2005).","journal-title":"Bioinformatics"},{"key":"98910_CR62","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/bioinformatics\/btr039","volume":"27","author":"MJ Sullivan","year":"2011","unstructured":"Sullivan, M. J., Petty, N. K. & Beatson, S. A. Easyfig: A genome comparison visualizer. Bioinformatics 27, 1009\u20131010 (2011).","journal-title":"Bioinformatics"},{"key":"98910_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/nar\/gkh152","volume":"32","author":"D Laslett","year":"2004","unstructured":"Laslett, D. & Canback, B. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucl. Acids Res. 32, 11\u201316 (2004).","journal-title":"Nucl. Acids Res."},{"key":"98910_CR64","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/nar\/gki366","volume":"33","author":"P Schattner","year":"2005","unstructured":"Schattner, P., Brooks, A. N. & Lowe, T. M. The tRNAscan-SE, snoscan and snoGPS web servers for the detection of tRNAs and snoRNAs. Nucl. Acids Res. 33, 686\u2013689 (2005).","journal-title":"Nucl. Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98910-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T21:08:56Z","timestamp":1675717736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98910-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98910"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98910-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19313"}}